Skip to main content
Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc. — Investor Relations & Filings

Ticker · RCUS ISIN · US03969F1093 US Manufacturing
Filings indexed 549 across all filing types
Latest filing 2026-01-05 Regulatory Filings
Country US United States of America
Listing US RCUS

About Arcus Biosciences, Inc.

https://arcusbio.com/

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer. The company's approach centers on creating both small molecules and antibodies designed to be combined for greater efficacy. Its pipeline of investigational medicines is guided by specific biologic mechanisms of cancer, with a strategy aimed at accelerating the development of novel combination treatments from early-stage clinical studies through to potential commercialization. Arcus Biosciences collaborates with the broader cancer community to advance its global clinical trials.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2026
Regulatory Filings
2026-01-05 English
Director's Dealing 2026
Director's Dealing
2026-01-02 English
Director's Dealing 2026
Director's Dealing
2026-01-02 English
Regulatory Filings 2025
Regulatory Filings
2026-01-01 English
FORM 4
Director's Dealing
2025-12-18 English
FORM 4
Director's Dealing
2025-12-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.